市场调查报告书
商品编码
1258915
到 2028 年的自动分析仪市场预测——分析仪、机翼类型、应用、最终用户和地区的全球分析Automated Analyzers Market Forecasts to 2028 - Global Analysis By Analyzer, Wing Type, Application, End User and By Geography |
根据Stratistics MRC,2022年全球自动化分析仪市场规模将达到75亿美元,预计2028年将达到127亿美元,预测期内增长9.1%。预计将以 CAGR 增长。
医学实验室仪器,称为自动分析仪,旨在快速有效地测量大量收集的生物样本中的各种化学成分和其他参数,而无需或很少有人为干预。 它还适用于医院、门诊诊所、外科和急诊室。
据世界卫生组织称,传染病是世界上最主要的死亡原因,每年造成超过 1300 万人死亡,其中二分之一的死亡发生在欠发达国家。
传染病的传播给医疗保健资源带来了巨大的压力。 嗜酸性粒细胞沉降率 (ESR) 检测的增加也可能部分归因于感染的增加,感染继续带来各种健康风险。 此外,政府的需求和对综合医疗保健系统日益增长的需求是市场扩张的主要因素。
自动分析仪是一个复杂的系统,需要专业知识来维护和操作。 规模较小或技术较不先进的医疗机构可能面临这样的挑战,因为他们没有必要的人员和资源来有效地使用这些系统。 这些系统的校准和维护不当可能导致测试结果不准确、诊断或治疗不当。 因此,这些因素可能会阻碍市场需求。
使用机器学习、机器人技术和人工智能等尖端技术的实验室自动化意味着自动化实验室任务,例如样品製备、分析和数据管理。 由于其许多好处,例如提高效率、准确性、可重复性、降低劳动力成本和周转时间,实验室自动化正在迅速获得采用并推动市场增长。
公司应大力投资培训员工以有效使用这些工具。 因此,在员工不具备必要技能的环境中,部署可能会受到限制,因此,部署可能会在一定程度上受到限制。 然而,自动分析仪产品的高价格、劳动力短缺和自动分析仪的复杂性预计会阻碍市场扩张。
许多政府实施的 COVID-19 大流行措施增加了对自动分析仪的需求,尤其是对诊断测试。 自动化分析仪可以快速准确地进行各种诊断,包括用于检测 SARS-CoV-2 的核酸扩增测试。 受非典疫情影响需求激增,自动分析仪为提高检测能力、缩短检测时间做出了巨大贡献。
由于临床化学和免疫测定的需求不断增长,预计免疫系统分析仪将实现利润丰厚的增长。 称为免疫系统分析仪的医疗设备会自动测试患者标本以检测生物活性成分。 这些分析仪主要用于诊断癌症、心脏病、自身免疫性疾病、传染病等。 免疫化学分析仪市场的发展有望扩大该领域的市场。
由于在基因组学中使用了自动化分析仪,预计基因组学部分在预测期内将以最快的复合年增长率增长。 这比手动分析更准确,表明大多数操作可以按顺序完成。 以合理的成本及时获取大量数据是许多研究的主要目标之一。 文库创建、测序和重复标记均由自动化基因组分析仪执行。
由于人们对心臟分析、过敏测试、血液计数等的认识不断提高,亚太地区预计在预测期内将占据最大的市场份额。 此外,医疗保健意识的提高、製药公司的增加以及血液病患者的增加有望促进该行业的发展。
由于医疗保健基础设施的改善以及主要製造商对研发活动的投资不断增加,预计北美在预测期内的复合年增长率最高。 此外,由于政府加大了对诊断分析仪自动化的力度,以及许多化学和製药行业在其研发业务中引入了自动化分析仪,预计该地区的市场将会增长。
自动化分析仪市场的主要参与者包括:Hudson Robotics Inc.、Thermo Fisher Scientific、Honeywell International Inc.、Tecan Group Ltd.、Becton Dickinson、Siemens Healthineers AG、Danaher Corporation , PerkinElmer Inc. Synchron Lab Automation, Agilent Technologies Inc, HORIBA Ltd., ELITechGroup, Ortho Clinical Diagnostics, Aurora Biomed, Eppendorf AG, Yokogawa Electric Corporation
2021 年 2 月,横河电机株式会社与 Hiroto Savio-Science Co., Ltd. (HBS) 共同宣布了癌症筛查服务“N-”,旨在扩大 NOSE 的使用范围,我们签署了一项投资合作协议。
2019 年 9 月,Thermo Fisher Scientific 宣布推出先进的高效液相色谱 (HPLC) 和三重四极桿质谱分析,用于对复杂样品基质中的农药进行可靠、灵敏的定量分析。我们设计了一种新的工作流程,提供经过验证的分析方法结合了 (MS) 功能。
购买此报告的客户将免费获得以下定制之一。
According to Stratistics MRC, the Global Automated Analyzers Market is accounted for $7.5 billion in 2022 and is expected to reach $12.7 billion by 2028 growing at a CAGR of 9.1% during the forecast period. A medical laboratory device called an automated analyzer may be created to quickly and effectively measure various chemical compositions and other parameters in a large number of gathered biological samples with little help from humans. Tools also allow for the examination of a wide variety of samples and the quick generation of data, indicating future uses for them in hospitals, outpatient clinics, and surgical as well as emergency wards.
According to the WHO, infectious diseases are the world's leading cause of death, accounting for more than 13 million deaths per year, with one in every two deaths occurring in underdeveloped nations.
The resources used by healthcare services are put under tremendous strain by the rising prevalence of infectious diseases. The increased number of Eosinophil Sedimentation Rate (ESR) tests is likely due in part to the increasing number of infectious infections that are continuously causing various health risks. Also, the requirements from the respective governments and the rising need for integrated healthcare systems are significant drivers of the market's expansion.
Automatic analyzers are frequently intricate systems that call for unique expertise to maintain and operate. Smaller or less technologically advanced healthcare providers could find this challenging since they do not have the staff or resources they need to use these systems efficiently. Inaccuracies in test results and improper diagnosis or treatment may come from improper calibration and upkeep of these systems. Thus, this factor may impede demand for the market.
Using cutting-edge technology like machine learning, robots, and artificial intelligence, laboratory automation entails automating operations in the lab, such as sample preparation, analysis, and data management. Laboratory automation is quickly being adopted because it provides numerous benefits such as enhanced efficiency, precision, and reproducibility, as well as lowers labour costs and turnaround time, which are driving market growth.
Businesses need to make significant investments in training their staff members on how to use these tools efficiently. This may limit their adoption in environments where staff could lack the necessary skills, which in turn may limit their acceptance to some extent. Yet the high cost of automated analyzer products, the labour shortage, and the increasing sophistication of automated analyzers will prove to be obstacles to the market's expansion.
The COVID-19 pandemic lockdown measures put in place by many governments have raised demand for automated analyzers, notably for diagnostic testing. Automatic analyzers may swiftly and accurately carry out a variety of diagnostic procedures, such as nucleic acid amplification tests for finding SARS-CoV-2, the virus that causes the disease. Throughout the epidemic, demand has increased dramatically, and automated analyzers have been crucial in boosting testing capacity and speeding up turnaround times.
The immuno-based analyzer segment is estimated to have a lucrative growth, due to growing demand in clinical chemistry and immunoassay. Medical devices called immuno-based analyzers automatically conduct tests on patient samples to find any biologically active components. These analyzers are mostly employed in the diagnosis of cancer, cardiac, autoimmune, and infectious illnesses. The market is anticipated to expand in this sector due to the development of immunochemistry analyzers.
The Genomics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the uses of automated analyzers in genomics. This indicates that the majority of operations can be completed in a sequential manner with more accuracy than manual analysis. Getting a lot of data in a timely manner at a fair cost is one of the main objectives for many studies. The creation of libraries, sequencing, and duplication marking are all tasks performed by automated analyzers in genomics.
Asia Pacific is projected to hold the largest market share during the forecast period owing to rise in the consciousness among the people about cardiac analysis, allergy testing, blood cell counts and others. In addition, rising healthcare awareness, an increase in the number of pharmaceutical firms in the area, and an increase in the number of patients with blood disorders are all expected to help the industry develop.
North America is projected to have the highest CAGR over the forecast period, owing to the existence of improved healthcare infrastructure and major manufacturers increasing the investments in R&D activities. Also, the region's market is expected to develop as a result of the government's increased efforts to automate diagnosis analyzers and the large number of chemical and pharmaceutical industries who have adopted automated analyzers for R&D operations.
Some of the key players profiled in the Automated Analyzers Market include: Hudson Robotics Inc., Thermo Fisher Scientific, Honeywell International Inc., Tecan Group Ltd., Becton Dickinson, Siemens Healthineers AG, Danaher Corporation, PerkinElmer Inc., Synchron Lab Automation, Agilent Technologies Inc., HORIBA, Ltd., ELITechGroup, Ortho Clinical Diagnostics, Aurora Biomed, Eppendorf AG and Yokogawa Electric Co., Ltd.
In February 2021, Yokogawa Electric Co., Ltd. and HIROT SUBIO SCIENCE (HBS) have signed an investment partnership agreement with the aim of expanding the use of HBS's N-NOSE cancer screening service, which detects cancer using the highly sensitive olfactory function of nematodes.
In September 2019, Thermo Fisher Scientific designed a new workflow to provide a validated analytical method combining advanced high-performance liquid chromatography (HPLC) and triple quadrupole mass spectrometry (MS) capabilities for the reliable and sensitive quantitation of pesticides in complex sample matrices.
All the customers of this report will be entitled to receive one of the following free customization options: